MeiraGTx Holdings plc Defined Benefit Plan, Plan Assets, Contributions by Employer
MeiraGTx Holdings plc (MGTX) reported Defined Benefit Plan, Plan Assets, Contributions by Employer of $2.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:DefinedBenefitPlanContributionsByEmployer · last filed 2024-03-15
- MeiraGTx Holdings plc defined benefit plan, plan assets, contributions by employer for fiscal 2023 was $2.50M, a 25.00% increase from fiscal 2022.
- MeiraGTx Holdings plc defined benefit plan, plan assets, contributions by employer for fiscal 2022 was $2.00M, a 11.11% increase from fiscal 2021.
- MeiraGTx Holdings plc defined benefit plan, plan assets, contributions by employer for fiscal 2021 was $1.80M, a 63.64% increase from fiscal 2020.
- MeiraGTx Holdings plc defined benefit plan, plan assets, contributions by employer for fiscal 2020 was $1.10M, a 82.03% increase from fiscal 2019.
| Period end | Defined Benefit Plan, Plan Assets, Contributions by Employer 12 month | Defined Benefit Plan, Plan Assets, Contributions by Employer 12 month as first filed |
|---|---|---|
| 2023-12-31 | $2.50M 10-K · filed 2024-03-15 | |
| 2022-12-31 | $2.00M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $1.80M 10-K · filed 2023-03-14 | |
| 2020-12-31 | $1.10M 10-K · filed 2022-03-10 | $1.09M 10-K · filed 2021-03-11 |
| 2019-12-31 | $604.29K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |